AVTR — Avantor Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapContrarian

Annual income statement for Avantor, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	7,386	7,512	6,967	6,784	6,552
Cost of Revenue
Gross Profit	2,503	2,603	2,364	2,279	2,139
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	6,426	6,395	6,278	5,710	6,803
Operating Profit	960	1,118	690	1,074	-251
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	753	851	411	854	-441
Provision for Income Taxes
Net Income After Taxes	573	687	321	712	-530
Net Income Before Extraordinary Items
Net Income	573	687	321	712	-530
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	508	662	321	712	-530
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.989	1.02	0.714	0.695	0.074